A detailed history of Verition Fund Management LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 39,519 shares of BVS stock, worth $460,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,519
Previous 15,419 156.3%
Holding current value
$460,001
Previous $80,000 183.75%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $95,436 - $167,013
24,100 Added 156.3%
39,519 $227,000
Q1 2024

May 14, 2024

SELL
$4.33 - $5.75 $2,165 - $2,875
-500 Reduced 3.14%
15,419 $80,000
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $14,834 - $27,410
5,133 Added 47.59%
15,919 $83,000
Q3 2023

Nov 14, 2023

BUY
$2.8 - $4.94 $30,200 - $53,282
10,786 New
10,786 $35,000
Q1 2023

May 15, 2023

BUY
$1.07 - $2.95 $12,640 - $34,851
11,814 Added 62.32%
30,770 $32,000
Q4 2022

Feb 14, 2023

BUY
$1.81 - $8.14 $34,310 - $154,301
18,956 New
18,956 $49,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $718M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.